Pathways of the heart

Circulation: Cardiovascular Genetics

Volumn 2, Issue 4, 2009, Pages 303-305

  Deo, Rahul C ^a,b   Roth, Frederick P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CLINICAL DECISION MAKING; COMPUTER PROGRAM; DISEASE MODEL; DNA MICROARRAY; EDITORIAL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DATABASE; HEART FAILURE; HUMAN; MOLECULAR GENETICS; MORTALITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; ANIMAL; DOG; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; GENE EXPRESSION PROFILING; GENETICS; HEART BUNDLE BRANCH BLOCK; NOTE; SIGNAL TRANSDUCTION;

ANIMALS; BUNDLE-BRANCH BLOCK; DISEASE MODELS, ANIMAL; DOGS; ECHOCARDIOGRAPHY, DOPPLER; GENE EXPRESSION PROFILING; HEART FAILURE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 77449104076     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.109.892588     Document Type: Editorial

References (11)

1. Loscalzo J, Kohane I, Barabasi AL. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007;3:124.
2. Potti A, Dressman HK, Bild A, RieDel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR. Genomic signatures to guiDe the use of chemotherapeutics. Nat Med. 2006;12:1294-1300.
3. Seidman JG, Seidman C. The genetic basis for cardiomyopathy: from mutation iDentification to mechanistic paradigms. Cell. 2001;104: 557-567.
4. Barth AS, Aiba T, Halperin V, DiSilvestre D, Chakir K, Colantuoni C, Tunin RS, Dimaano VL, Yu W, Abraham MR, Peltonen L. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet. 2009;2: 371-378.
5. Hasan A, Abraham WT. Cardiac resynchronization treatment of heart failure. Annu Rev Med. 2007;58:63-74.
6. Berriz GF, King OD, Bryant B, SanDer C, Roth FP. Characterizing gene sets with FuncAssociate. Bioinformatics. 2003;19:2502-2504.
7. Lamb J, Crawford ED, Peck D, MoDell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, LanDer ES, Golub TR. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313: 1929-1935.
8. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR. Oncogenic pathway signatures in human cancers as a guiDe to targeted therapies. Nature. 2006;439:353-357.
9. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wiDe expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
10. Bohen SP, Troyanskaya OG, Alter O, Warnke R, Botstein D, Brown PO, Levy R. Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci USA. 2003;100: 1926-1930.
11. Hughes TR, Marton MJ, Jones AR, Roberts CJ, Stoughton R, Armour CD, Bennett HA, Coffey E, Dai H, He YD, Kidd MJ, King AM, Meyer MR, SlaDe D, Lum PY, Stepaniants SB, Shoemaker DD, Gachotte D, Chakraburtty K, Simon J, Bard M, Friend SH. Functional discovery via a compendium of expression profiles. Cell. 2000;102:109-126.